APA

Thiébaut R., Hue S., Le Marec F., Lelièvre J., Dupon M., Foucat E., Lazaro E., Dabis F., Duffau P., Wittkop L., Surenaud M., Pellegrin I., Lacabaratz C., Bonnet F. & Lévy Y. (20180604). Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. : AIDS (London, England).

Chicago

Thiébaut Rodolphe, Hue Sophie, Le Marec Fabien, Lelièvre Jean-Daniel, Dupon Michel, Foucat Emile, Lazaro Estibaliz, Dabis François, Duffau Pierre, Wittkop Linda, Surenaud Mathieu, Pellegrin Isabelle, Lacabaratz Christine, Bonnet Fabrice and Lévy Yves. 20180604. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. : AIDS (London, England).

Harvard

Thiébaut R., Hue S., Le Marec F., Lelièvre J., Dupon M., Foucat E., Lazaro E., Dabis F., Duffau P., Wittkop L., Surenaud M., Pellegrin I., Lacabaratz C., Bonnet F. and Lévy Y. (20180604). Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. : AIDS (London, England).

MLA

Thiébaut Rodolphe, Hue Sophie, Le Marec Fabien, Lelièvre Jean-Daniel, Dupon Michel, Foucat Emile, Lazaro Estibaliz, Dabis François, Duffau Pierre, Wittkop Linda, Surenaud Mathieu, Pellegrin Isabelle, Lacabaratz Christine, Bonnet Fabrice and Lévy Yves. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. : AIDS (London, England). 20180604.